Matches in Wikidata for { <http://www.wikidata.org/entity/Q33357357> ?p ?o ?g. }
- Q33357357 description "2003 nî lūn-bûn" @default.
- Q33357357 description "2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած" @default.
- Q33357357 description "2003 թվականի հոտեմբերին հրատարակված գիտական հոդված" @default.
- Q33357357 description "2003年の論文" @default.
- Q33357357 description "2003年学术文章" @default.
- Q33357357 description "2003年学术文章" @default.
- Q33357357 description "2003年学术文章" @default.
- Q33357357 description "2003年学术文章" @default.
- Q33357357 description "2003年学术文章" @default.
- Q33357357 description "2003年學術文章" @default.
- Q33357357 description "2003年學術文章" @default.
- Q33357357 description "2003年學術文章" @default.
- Q33357357 description "2003年學術文章" @default.
- Q33357357 description "2003年學術文章" @default.
- Q33357357 description "2003年學術文章" @default.
- Q33357357 description "2003년 논문" @default.
- Q33357357 description "article científic" @default.
- Q33357357 description "article scientific" @default.
- Q33357357 description "article scientifique (publié 2003)" @default.
- Q33357357 description "articol științific" @default.
- Q33357357 description "articolo scientifico" @default.
- Q33357357 description "artigo científico (publicado na 2003)" @default.
- Q33357357 description "artigo científico (publicado na 2003)" @default.
- Q33357357 description "artigo científico" @default.
- Q33357357 description "artikull shkencor" @default.
- Q33357357 description "artikulong pang-agham" @default.
- Q33357357 description "artykuł naukowy" @default.
- Q33357357 description "artículo científico publicado en 2003" @default.
- Q33357357 description "artículu científicu espublizáu en 2003" @default.
- Q33357357 description "bilimsel makale" @default.
- Q33357357 description "bài báo khoa học" @default.
- Q33357357 description "mokslinis straipsnis" @default.
- Q33357357 description "naučni članak" @default.
- Q33357357 description "scienca artikolo" @default.
- Q33357357 description "scientific article" @default.
- Q33357357 description "teaduslik artikkel" @default.
- Q33357357 description "tieteellinen artikkeli" @default.
- Q33357357 description "tudományos cikk" @default.
- Q33357357 description "vedecký článok" @default.
- Q33357357 description "vetenskaplig artikel" @default.
- Q33357357 description "videnskabelig artikel (udgivet 2003)" @default.
- Q33357357 description "vitenskapelig artikkel" @default.
- Q33357357 description "vitskapeleg artikkel" @default.
- Q33357357 description "vědecký článek" @default.
- Q33357357 description "wetenschappelijk artikel" @default.
- Q33357357 description "wissenschaftlicher Artikel" @default.
- Q33357357 description "επιστημονικό άρθρο" @default.
- Q33357357 description "мақолаи илмӣ" @default.
- Q33357357 description "мақолаи илмӣ" @default.
- Q33357357 description "наукова стаття, опублікована в жовтні 2003" @default.
- Q33357357 description "научна статия" @default.
- Q33357357 description "научная статья" @default.
- Q33357357 description "научни чланак" @default.
- Q33357357 description "научни чланак" @default.
- Q33357357 description "מאמר מדעי" @default.
- Q33357357 description "سائنسی مضمون" @default.
- Q33357357 description "مقالة علمية نشرت بتاريخ 28-10-2003" @default.
- Q33357357 description "مقالهٔ علمی" @default.
- Q33357357 description "২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33357357 description "บทความทางวิทยาศาสตร์" @default.
- Q33357357 description "სამეცნიერო სტატია" @default.
- Q33357357 name "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 name "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 name "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 type Item @default.
- Q33357357 label "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 label "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 label "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 prefLabel "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 prefLabel "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 prefLabel "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 P1433 Q33357357-9D2F0E0B-8C7A-42A6-A52C-74338BF78DEA @default.
- Q33357357 P1476 Q33357357-9A8BCD1A-15DB-4D6B-874F-C1CFA4560396 @default.
- Q33357357 P2093 Q33357357-0A0D3A3B-2916-4B81-B8EC-B7CE0FE28098 @default.
- Q33357357 P2093 Q33357357-0C76D18C-281F-4990-BB3E-8964AB266FE4 @default.
- Q33357357 P2093 Q33357357-34B66EAF-3E0E-473A-A422-A1AFD614C564 @default.
- Q33357357 P2093 Q33357357-3C6C4B9E-00AA-4AED-8259-AC8030C2C628 @default.
- Q33357357 P2093 Q33357357-4395FC89-F9E7-490D-8C34-EC509E3EC94C @default.
- Q33357357 P2093 Q33357357-60BA2EE9-A258-41B7-8246-203CD0DE31B5 @default.
- Q33357357 P2093 Q33357357-6C18BC68-C8FE-4EEF-A887-E186ED4AADBC @default.
- Q33357357 P2093 Q33357357-BAA1E405-04A0-4D49-8AB8-FE7F53FB1D41 @default.
- Q33357357 P2093 Q33357357-F1C2605F-D67E-4A41-ABA3-8764FD891DEF @default.
- Q33357357 P2860 Q33357357-5AA001A6-224E-4257-951D-83B4F489A263 @default.
- Q33357357 P2860 Q33357357-F2FC0542-45FE-439C-A4E9-2AF4B66FC41C @default.
- Q33357357 P2888 Q33357357-BFE9DBA5-7E93-4A1C-A017-6BF83B74E040 @default.
- Q33357357 P304 Q33357357-2BD38C34-C862-442B-A851-0CE93BC8AE74 @default.
- Q33357357 P31 Q33357357-5E6C89D9-448F-4A6F-A908-66EC9C01A8C5 @default.
- Q33357357 P356 Q33357357-AB01CC51-8D89-4675-9C76-A774C16D7249 @default.
- Q33357357 P433 Q33357357-79B92B32-4564-4C9B-B26A-558FA7C90B47 @default.
- Q33357357 P478 Q33357357-BB26A4BA-E83F-4C4D-ABB5-17761078C533 @default.
- Q33357357 P577 Q33357357-8B00B24A-145B-4351-B4AD-C9254D3A11F9 @default.
- Q33357357 P6179 Q33357357-8053A2ED-7955-4F62-B899-F8EBF5E57194 @default.
- Q33357357 P698 Q33357357-94750BA6-93B4-4712-83C4-921C30B06BCE @default.
- Q33357357 P8608 Q33357357-414C8CAA-7BAB-4C04-89D3-79560F782EBC @default.
- Q33357357 P356 BF02665346 @default.
- Q33357357 P698 14586557 @default.
- Q33357357 P1433 Q326137 @default.
- Q33357357 P1476 "A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan" @default.
- Q33357357 P2093 "A Duggal" @default.
- Q33357357 P2093 "Andrzej P Kudelka" @default.